These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17049769)

  • 21. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: physicochemical and technological characterisation.
    Marinich JA; Ferrero C; Jiménez-Castellanos MR
    Eur J Pharm Biopharm; 2009 May; 72(1):138-47. PubMed ID: 19146956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Roll compaction/dry granulation: effect of raw material particle size on granule and tablet properties.
    Herting MG; Kleinebudde P
    Int J Pharm; 2007 Jun; 338(1-2):110-8. PubMed ID: 17324537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Importance of evaluating the consolidation of granules manufactured by high shear mixer.
    Ohno I; Hasegawa S; Yada S; Kusai A; Moribe K; Yamamoto K
    Int J Pharm; 2007 Jun; 338(1-2):79-86. PubMed ID: 17321085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Granule breakage during drying processes.
    Nieuwmeyer FJ; van der Voort Maarschalk K; Vromans H
    Int J Pharm; 2007 Feb; 329(1-2):81-7. PubMed ID: 17005339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation of redispersible dry nanocapsules by means of spray-drying: development and characterisation.
    Tewa-Tagne P; Briançon S; Fessi H
    Eur J Pharm Sci; 2007 Feb; 30(2):124-35. PubMed ID: 17150339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative study of dissolution characteristics of polymeric and wax granulations of theophylline and their tablets.
    Uhumwangho MU; Okor RS
    Pak J Pharm Sci; 2008 Jul; 21(3):230-6. PubMed ID: 18614417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of particle properties on the flowability of ibuprofen powders.
    Liu LX; Marziano I; Bentham AC; Litster JD; White ET; Howes T
    Int J Pharm; 2008 Oct; 362(1-2):109-17. PubMed ID: 18652883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breakage and drying behaviour of granules in a continuous fluid bed dryer: Influence of process parameters and wet granule transfer.
    De Leersnyder F; Vanhoorne V; Bekaert H; Vercruysse J; Ghijs M; Bostijn N; Verstraeten M; Cappuyns P; Van Assche I; Vander Heyden Y; Ziemons E; Remon JP; Nopens I; Vervaet C; De Beer T
    Eur J Pharm Sci; 2018 Mar; 115():223-232. PubMed ID: 29374528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eudragit E as excipient for production of granules and tablets from Phyllanthus niruri L spray-dried extract.
    Pereira de Souza T; Martínez-Pacheco R; Gómez-Amoza JL; Petrovick PR
    AAPS PharmSciTech; 2007 Apr; 8(2):Article 34. PubMed ID: 17622112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of drying methods on granule and tablet properties.
    Femi-Oyewo MN; Nasipuri RN
    Pharmazie; 1987 Sep; 42(9):608-10. PubMed ID: 3432346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of sustained release fast-disintegrating tablets using various polymer-coated ion-exchange resin complexes.
    Jeong SH; Park K
    Int J Pharm; 2008 Apr; 353(1-2):195-204. PubMed ID: 18164882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formation of indomethacin-saccharin cocrystals using supercritical fluid technology.
    Padrela L; Rodrigues MA; Velaga SP; Matos HA; de Azevedo EG
    Eur J Pharm Sci; 2009 Aug; 38(1):9-17. PubMed ID: 19477273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanistic modelling of the drying behaviour of single pharmaceutical granules.
    Mortier ST; De Beer T; Gernaey KV; Vercruysse J; Fonteyne M; Remon JP; Vervaet C; Nopens I
    Eur J Pharm Biopharm; 2012 Apr; 80(3):682-9. PubMed ID: 22230798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formation of hollow core granules by fluid bed in situ melt granulation: modelling and experiments.
    Ansari MA; Stepanek F
    Int J Pharm; 2006 Sep; 321(1-2):108-16. PubMed ID: 16787722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of quality attributes of continuously produced granules using complementary pat tools.
    Fonteyne M; Soares S; Vercruysse J; Peeters E; Burggraeve A; Vervaet C; Remon JP; Sandler N; De Beer T
    Eur J Pharm Biopharm; 2012 Oct; 82(2):429-36. PubMed ID: 22892292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production of morphology-controllable porous hyaluronic acid particles using a spray-drying method.
    Iskandar F; Nandiyanto AB; Widiyastuti W; Young LS; Okuyama K; Gradon L
    Acta Biomater; 2009 May; 5(4):1027-34. PubMed ID: 19114316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Compressibility and compactibility of granules produced by wet and dry granulation.
    Bacher C; Olsen PM; Bertelsen P; Sonnergaard JM
    Int J Pharm; 2008 Jun; 358(1-2):69-74. PubMed ID: 18407441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Impact of Granule Density on Tabletting and Pharmaceutical Product Performance.
    van den Ban S; Goodwin DJ
    Pharm Res; 2017 May; 34(5):1002-1011. PubMed ID: 28188541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In-line monitoring of granule moisture in fluidized-bed dryers using microwave resonance technology.
    Buschmüller C; Wiedey W; Döscher C; Dressler J; Breitkreutz J
    Eur J Pharm Biopharm; 2008 May; 69(1):380-7. PubMed ID: 17976965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.